KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Finished Goods: 2013-2025

Historic Finished Goods for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to $9.5 million.

  • CareDx's Finished Goods rose 75.49% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 75.49%. This contributed to the annual value of $4.8 million for FY2024, which is 31.74% up from last year.
  • CareDx's Finished Goods amounted to $9.5 million in Q3 2025, which was up 13.60% from $8.4 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Finished Goods registered a high of $9.5 million during Q3 2025, and its lowest value of $2.4 million during Q1 2021.
  • Moreover, its 3-year median value for Finished Goods was $4.4 million (2025), whereas its average is $5.0 million.
  • The largest annual percentage gain for CareDx's Finished Goods in the last 5 years was 129.79% (2021), contrasted with its biggest fall of 46.83% (2021).
  • Quarterly analysis of 5 years shows CareDx's Finished Goods stood at $3.9 million in 2021, then fell by 24.26% to $3.0 million in 2022, then climbed by 23.50% to $3.7 million in 2023, then soared by 31.74% to $4.8 million in 2024, then spiked by 75.49% to $9.5 million in 2025.
  • Its last three reported values are $9.5 million in Q3 2025, $8.4 million for Q2 2025, and $4.4 million during Q1 2025.